Navigation Links
Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Date:9/19/2011

SAN DIEGO, Sept. 19, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that the first patient was dosed in the Company's Phase I clinical trial of its lead drug candidate ME-143 in patients with refractory solid tumors. The trial, conducted in collaboration with the Sarah Cannon Research Institute, is expected to enroll up to 24 patients with final data collected by the second quarter of 2012.

Fiscal Year End Conference Call

Marshall Edwards also announced that its management team will host a conference call with simultaneous webcast on Thursday, September 29, 2011, beginning at 5:00 p.m. Eastern time. Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present an overview of the Company; Robert Mass, MD, Chief Medical Officer, will discuss the Company's lead oncology drug candidates, including an update on the Phase I clinical trial of ME-143; and Thomas Zech, Chief Financial Officer, will provide a summary of the Company's fiscal year ended June 30, 2011 financial results.

To access the live call, please dial 866-800-8652 (toll-free) or 617-614-2705 (international), participant passcode 14784577. A replay of the call will be available approximately two hours after the conclusion of the call. To access the replay, please dial 888-286-8010 (toll-free) or 617-801-6888 (international), passcode 99793585. The conference call will also be webcast live and can be accessed at www.marshalledwardsinc.com/investor. Please connect several minutes prior to the start of the webcast to ensure adequate time for any software downloads that may be required.

About the Phase I Clinical Trial of ME-143

The Phase I trial of ME-143 was initiated earlier
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 Gary A. Puckrein , PhD, ... Forum (NMQF), today will present an award to ... Research and Manufacturers of America (PhRMA), for his ... behalf of PhRMA, and in conjunction with NMQF, Castellani ... awareness, start conversations, and increase diversity in clinical trials, ...
(Date:4/21/2015)... -- The North American dermatology diagnostic devices market is ... 2014 to 2019. Although mature markets (the U.S. and ... the dermatology diagnostic devices market, Mexico ... of 9.8% during the forecast period. The growth of ... such as rising incidences of skin disorders, increasing demand ...
(Date:4/21/2015)... April 21, 2015 Softheon, Inc., ... integration and business operation, has confirmed its status ... Centers of Medicare & Medicaid Services (CMS).  Under ... with access to the Federal Data Hub to ... into qualified health insurance plans. ...
Breaking Medicine Technology:National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 2North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 3Softheon Confirms Web Broker Entity (WBE) Status with the Centers of Medicare & Medicaid Services (CMS) 2
(Date:4/21/2015)... 2015 On April 8th, 2015, Choices ... at the world famous Avalon Hollywood. Organized by Debbie ... in TV and film, the EcoLuxe Lounge is a ... awards ceremonies and festivals throughout the year. A gathering ... and socially conscious products and services, this daylong event ...
(Date:4/21/2015)... Colmar, PA (PRWEB) April 21, 2015 ... Ichthyosis & Related Skin Types, Inc.® (FIRST) will publish ... ichthyosis. The campaign will run throughout the month of ... Voice. It Matters to Someone." The positioning was ... about this rare skin disorder and to help support ...
(Date:4/21/2015)... 21, 2015 Approximately 75 million Americans ... U.S. Environmental Protection Agency (EPA). On top of this, ... smoke increase the level of toxins found in the ... these harmful toxins is to increase consumption of broccoli. ... highest level of glucoraphanin – a long-lasting antioxidant – ...
(Date:4/21/2015)... 21, 2015 As a provider of ... found that their rehabilitation strategy, which involves various treatment ... relapses. In an effort to offer hope and encouragement ... their lives, Best Drug Rehabilitation has featured a series ... many successful graduates of their recovery program. , ...
(Date:4/21/2015)... Zane Benefits, the leader in individual ... publication of a new guide “Health Reimbursement Accounts in ... the health insurance industry, including how employers can use ... what is permitted when implementing an HRA. This simple, ... which HRAs are compliant this year. , According ...
Breaking Medicine News(10 mins):Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Best Drug Rehabilitation Graduate Discusses Making Amends and Rebuilding Relationships 2
... Inc. and TPABenefits, Inc.,of San Antonio, TX announced ... INETICO system and the TPABenefits Web Portal. This ... Pre-Certification,and Wellness data source and allows Payors, TPA,s, ... Case Notes on the,TPABenefits Web Portal., The ...
... Calif., May 8 IRIDEX,Corporation (Nasdaq: IRIX ) ... financial results after the market closes on Tuesday, May ... host a conference,call with the investment community at 5:00 ... the results of the quarter and other business,developments., ...
... Viruses are masters of deception, duping their host,s cells ... has found that human cytomegalovirus (HCMV) can mimic a ... disrupting a cell,s primary anti-cancer mechanism. , Writing in ... University of Wisconsin-Madison and Harvard Medical School report that ...
... disease, osteoarthritis (OA) is the leading cause of disability in ... OA most often strikes the knee, particularly the inner aspect ... this vulnerable joint compartment is the knee adduction moment, an ... increase in the peak knee adduction moment is associated with ...
... More than 8,700 babies born each year in Washington to ... is,one of the best things a woman can do to ... time for Mother,s Day on May 11, the state,Department of ... Line,to provide pregnant women with more help when they,re ready ...
... MADISON, Wis., May 8 Let,s face it,Americans ... prove,positive, like when it promotes greater awareness and ... of cancer, lung cancer,causes almost twice as many ... today launched a national, multi-media public service,announcement (PSA) ...
Cached Medicine News:Health News:INETICO, Inc. Creates Data Interface with TPABenefits, Inc. Offering a Powerful Care and Claims Management Solution 2Health News:Virus mimics human protein to hijack cell division machinery 2Health News:Cane use may reduce risk of knee osteoarthritis progression 2Health News:Cane use may reduce risk of knee osteoarthritis progression 3Health News:Tobacco Quit Line Expands Services for Pregnant Women Who Smoke 2Health News:National Lung Cancer Partnership Launches Campaign to Raise Lung Cancer Awareness Among Women 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: